Health insurers will not be covering the cost of a new obesity medication coming on to the market in Ireland. Mounjaro, a ...

As a result, it will be available only on private prescription at a cost of €215 or more a month. That equates to an annual ...

Ozempic and other glucagon-like peptide-1 (GLP-1) agonists are a transformative new class of medicines for the treatment of ...

Use precise geolocation data. Actively scan device characteristics for identification. Store and/or access information on a ...

Until this week, everything was going marvellously. My size 12 jeans were gaping at the waistline, and I could slip into a ...

Tirzepatide will be available at pharmacies in Ireland initially in doses of 2.5 mg and 5 mg, with availability of higher ...

The remarkable efficacy of new diabetes and weight loss medicines like Ozempic and Mounjaro have been one of the biggest health stories of recent years. Despite rising rates of diabetes and obesity, ...

Eli Lilly and Company LLY reported fourth-quarter 2024 adjusted earnings per share (“EPS”) of $5.32, which beat the Zacks ...

The world’s biggest drugmaker Eli Lilly has forecast that profits for the year will beat expectations, after two choppy quarters when disappointing sales of its blockbuster weight-loss drugs led to ...

Eli Lilly’s profit doubled in the fourth quarter, propelled by its hot-selling diabetes and obesity treatments, and the drugmaker came out with a mostly better-than-expected 2025 forecast. Sales ...

Eli Lilly forecast annual profit largely above Wall Street estimates on Thursday, banking on the launch of its popular ...

Advocates say microdosing reduces costs and side effects while maintaining weight loss, then can help with weight maintenance ...